Tandem Diabetes Care, Inc. (TNDM)

43,50 -1,22 (-2,73 %) À la clôture : 04:00PM EDT

Tandem Diabetes Care, Inc.

12400 High Bluff Drive
San Diego, CA 92130
United States
858 366 6900
https://www.tandemdiabetes.com

Secteur(s): Healthcare
Secteur d’activité: Medical Devices
Employés à temps plein: 2 400

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. John F. Sheridan	President, CEO & Director	988,35k	S.O.	1955
Ms. Leigh A. Vosseller	Executive VP, CFO & Treasurer	543,38k	S.O.	1974
Ms. Susan M. Morrison	Executive VP & Chief Administrative Officer	538,21k	S.O.	1979
Mr. David B. Berger Esq.	Transitional Advisor	543,38k	223,28k	1970
Mr. Brian B. Hansen	Executive Officer	561,74k	S.O.	1968
Ms. Elizabeth Anne Gasser	Executive Vice President and Chief Strategy & Product Officer	542,91k	S.O.	1976
Mr. Mark Novara	Executive VP & Chief Commercial Officer	169,6k	S.O.	1975
Mr. Rick A. Carpenter	Chief Technical Officer	S.O.	S.O.	1963
Ms. Shannon M. Hansen	Executive VP, Chief Legal, Privacy & Compliance Officer and Secretary	S.O.	S.O.	1966
Mr. Tom Fox	Chief Human Resources Officer	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Tandem Diabetes Care, Inc. en date du 1 mai 2024 est 2. Les scores principaux sont Audit : 3; Société : 1; Droits des actionnaires : 4; Compensation : 4.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.